Cogstate (ASX:CGS) is focused on the development and commercialisation of digital cognitive assessment tools. The company's products are used by researchers and clinicians around the world to assess cognitive function in a variety of settings, including clinical trials, clinical practice, and academic research. Cogstate's operations are focused on the commercialization of its digital cognitive assessment tools in the United States, Europe, and other markets. The company also provides a range of services, such as data analysis and consulting services.